JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress

Reactive oxygen species (ROS) are implicated in the pathophysiology of various diseases, including cancer. In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS. Using junD-deficient cells, we demonstrate that JunD regulates genes involved in antioxidant defense, H2O2 production, and angiogenesis. The accumulation of H2O2 in junD-/- cells decreases the availability of FeII and reduces the activity of HIF prolyl hydroxylases (PHDs) that target hypoxia-inducible factors-alpha (HIFalpha) for degradation. Subsequently, HIF-alpha proteins accumulate and enhance the transcription of VEGF-A, a potent proangiogenic factor. Our study uncovers the mechanism by which JunD protects cells from oxidative stress and exerts an antiangiogenic effect. Furthermore, we provide new insights into the regulation of PHD activity, allowing immediate reactive adaptation to changes in O2 or iron levels in the cell.

[1]  A. Giaccia,et al.  HIF-1 as a target for drug development , 2003, Nature Reviews Drug Discovery.

[2]  Cynthia Cohen,et al.  Reactive oxygen generated by Nox1 triggers the angiogenic switch , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[4]  M. Ivan,et al.  The von Hippel-Lindau tumor suppressor protein. , 2001, Current opinion in genetics & development.

[5]  M. Yaniv,et al.  The mammalian Jun proteins: redundancy and specificity , 2001, Oncogene.

[6]  G. Breier,et al.  Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.

[7]  R. Bravo,et al.  The jun and fos protein families are both required for cell cycle progression in fibroblasts , 1991, Molecular and cellular biology.

[8]  H. Forman,et al.  Oxidants as stimulators of signal transduction. , 1997, Free radical biology & medicine.

[9]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[10]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[11]  J. Pouysségur,et al.  HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia , 2003, The EMBO journal.

[12]  E. Keshet,et al.  Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Weitzman,et al.  JunD protects cells from p53-dependent senescence and apoptosis. , 2000, Molecular cell.

[14]  P. Ratcliffe,et al.  The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. , 2003, Seminars in cancer biology.

[15]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[16]  A. Nussler,et al.  Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. , 2001, Cancer research.

[17]  J. Fandrey,et al.  Reactive oxygen species as regulators of oxygen dependent gene expression. , 2000, Advances in experimental medicine and biology.

[18]  R. Wenger,et al.  Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  C. Li,et al.  Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Sutphin,et al.  Role of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1α* , 2002, The Journal of Biological Chemistry.

[21]  J. Pouysségur,et al.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. , 2000, The Journal of biological chemistry.

[22]  M. Karin,et al.  AP-1 as a regulator of cell life and death , 2002, Nature Cell Biology.

[23]  Michael I. Wilson,et al.  C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation , 2001, Cell.

[24]  A. Harris,et al.  Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. , 2003, Cancer research.

[25]  M. Yaniv,et al.  Variations in Jun and Fos protein expression and AP-1 activity in cycling, resting and stimulated fibroblasts , 1997, Oncogene.

[26]  Michael I. Wilson,et al.  Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation , 2001, Science.

[27]  C. Cooper,et al.  Electron paramagnetic resonance spectroscopy of iron complexes and iron-containing proteins. , 1993, Methods in enzymology.

[28]  G. Semenza,et al.  General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Yaniv,et al.  Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras , 1994, Cell.

[30]  A. Jaiswal,et al.  Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes , 1998, Oncogene.

[31]  J. Fandrey.  Hypoxia-inducible gene expression. , 1995, Respiration physiology.

[32]  J. Worrall,et al.  Paramagnetic resonance of biological metal centers. , 2002, Annual review of biophysics and biomolecular structure.

[33]  Dirk Bohmann,et al.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.

[34]  H. Jasper,et al.  JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. , 2003, Developmental cell.

[35]  M. Yaniv,et al.  Transformation by ras modifies AP1 composition and activity , 1997, Oncogene.

[36]  N. Chandel,et al.  Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[38]  J. Zweier,et al.  Mitogenic Signaling Mediated by Oxidants in Ras-Transformed Fibroblasts , 1997, Science.

[39]  W. Toone,et al.  Distinct regulatory proteins control the graded transcriptional response to increasing H(2)O(2) levels in fission yeast Schizosaccharomyces pombe. , 2002, Molecular biology of the cell.

[40]  E. Wagner,et al.  AP-1 – Introductory remarks , 2001, Oncogene.

[41]  P. Ratcliffe,et al.  Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. , 2001, Blood.

[42]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[43]  S. Fetzner,et al.  The 2Fe2S centres of the 2-oxo-1,2-dihydroquinoline 8-monooxygenase from Pseudomonas putida 86 studied by EPR spectroscopy. , 1995, Biochimica et biophysica acta.

[44]  F. Agani,et al.  The Role of Mitochondria in the Regulation of Hypoxia-inducible Factor 1 Expression during Hypoxia* , 2000, The Journal of Biological Chemistry.

[45]  M. Barbacid.  ras genes. , 1987, Annual review of biochemistry.

[46]  P. Ratcliffe,et al.  Regulation of angiogenesis by hypoxia: role of the HIF system , 2003, Nature Medicine.

[47]  D. Townsend,et al.  The role of glutathione-S-transferase in anti-cancer drug resistance , 2003, Oncogene.

[48]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[49]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[50]  M. King,et al.  Oxygen Sensing and HIF-1 Activation Does Not Require an Active Mitochondrial Respiratory Chain Electron-transfer Pathway* , 2001, The Journal of Biological Chemistry.

[51]  D. Peet,et al.  Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch , 2002, Science.

[52]  M. Ewen,et al.  Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein , 1997, Nature.

[53]  William Kim,et al.  The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. , 2003, Current opinion in genetics & development.

[54]  H. Green,et al.  QUANTITATIVE STUDIES OF THE GROWTH OF MOUSE EMBRYO CELLS IN CULTURE AND THEIR DEVELOPMENT INTO ESTABLISHED LINES , 1963, The Journal of cell biology.

[55]  F. Ismail-Beigi,et al.  Regulation of glut1 mRNA by Hypoxia-inducible Factor-1 , 2001, The Journal of Biological Chemistry.

[56]  J. Lambeth,et al.  The Superoxide-Generating Oxidase Nox1 Is Functionally Required for Ras Oncogene Transformation , 2004, Cancer Research.

[57]  R. Johnson,et al.  c‐Jun regulates cell cycle progression and apoptosis by distinct mechanisms , 1999, The EMBO journal.

[58]  Susan J. Brown,et al.  The nuclear receptor homologue Ftz-F1 and the homeodomain protein Ftz are mutually dependent cofactors , 1997, Nature.

[59]  K. Jungermann,et al.  A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression , 2004, Proceedings of the National Academy of Sciences of the United States of America.